Bydureon BCise 2 mg/0.85 mL prefilled autoinjector Images
Generic Name: exenatide
This medication has been identified as Bydureon BCise 2 mg/0.85 mL prefilled autoinjector. It is supplied by AstraZeneca.
Bydureon BCise is used in the treatment of Diabetes, Type 2 and belongs to the drug class incretin mimetics. Risk cannot be ruled out during pregnancy. Bydureon BCise 2 mg/0.85 mL prefilled autoinjector is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Bydureon BCise
- Generic Name
- exenatide
- Strength
- 2 mg/0.85 mL prefilled autoinjector
- Availability
- Prescription only
- Drug Class
- Incretin mimetics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-6540
More about Bydureon BCise (exenatide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (56)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: incretin mimetics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.